This site is intended for health professionals only.
Newsletter sign-up
My Account
Log In
News
Community
Interviews
Views
Analysis
In Practice
Interviews
Views
Analysis
Clinical
Allergy
Cancer
Cardiovascular
Dermatology and wound care
Diabetes and endocrinology
Ear nose and throat
Long-term conditions
Mental health and addiction
Musculoskeletal and rheumatology
Men's health
Nutrition and gastroenterology
Obesity & nutrition
Pain
Respiratory
Renal medicine and urology
Sexual health
Smoking cessation
Travel health
Vaccinations and infections
Women's health
All clinical
Pharmacy First
Clinical Ambassadors
Healthy living
Men's health
Minor ailments
Pain management
Seasonal health
Skincare
Travel health services
Vaccination
Women's health
All services
News
Community
Interviews
Views
Analysis
In Practice
Interviews
Views
Analysis
Clinical
Allergy
Cancer
Cardiovascular
Dermatology and wound care
Diabetes and endocrinology
Ear nose and throat
Long-term conditions
Mental health and addiction
Musculoskeletal and rheumatology
Men's health
Nutrition and gastroenterology
Obesity & nutrition
Pain
Respiratory
Renal medicine and urology
Sexual health
Smoking cessation
Travel health
Vaccinations and infections
Women's health
All clinical
Pharmacy First
Clinical Ambassadors
Healthy living
Men's health
Minor ailments
Pain management
Seasonal health
Skincare
Travel health services
Vaccination
Women's health
All services
Home
GLP-1 receptor agonists
Topic: GLP-1 receptor agonists
Latest
Diabetes drug shows potential in treating Parkinson’s disease
Clinical
Regulators issue statement on GLP-1 RA prescribing
20th July 2023
Search
